Bupropion, the atypical antidepressant used in smoke cessation: an in vitro study on its effects on human sperm function

Abstract

Objective

To assess the effects of the active metabolite of Bupropion, hydroxybupropion, on human spermatozoa in vitro.

Design

Laboratory based in vitro study.

Patients

Human sperm samples were collected from 45 normozoospermic patients (smokers and nonsmokers).

Exposure

Sperm samples were incubated at 37°C with 5% CO₂ for 2 hours with and without the IC₅₀ concentration of hydroxybupropion (1.9 μM).

Main Outcome Measures

Several sperm analysis were performed, including vitality, motility, chromatin condensation, DNA fragmentation, oxidative stress, mitochondria membrane potential, and acrosome integrity. High-speed video microscopy and Computer-Assisted Sperm Analysis provided a detailed evaluation of sperm motility.

Results

Hydroxybupropion exposure resulted in significant impairments in sperm vitality and motility, particularly in progressive motility. Chromatin condensation was significantly reduced, whereas DNA fragmentation, especially in the equatorial region, significantly increased. Mitochondria membrane potential, acrosomal integrity, and reactive oxygen species production also significantly decreased after exposure.

Conclusion

The findings indicate potential harm to sperm parameters, which may contribute to infertility. Understanding how Bupropion affects reproductive function is crucial for clinicians and patients to make informed decisions regarding the use of this medication.